Search

everythinglearnresearchcommunity

for

Search:↓

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Non-obese women with hair loss have higher heart disease risk.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Daily low-dose aspirin lowers minoxidil's effectiveness for hair loss treatment.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Minoxidil with propranolol and diuretics lowers blood pressure but causes fluid retention and hair growth.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

AHR ligands could treat inflammatory skin diseases.

Minoxidil effectively controls blood pressure in severe cases, but may cause fluid retention and edema.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.